Aptevo Therapeutics Inc. (APVO) stock
APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.46−0.09 (-15.97%)
Close on Nov 17, 2026Market cap $830.71KP/E –Yield –
Aptevo Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Aptevo Therapeutics's total debt was $3.46M at Dec 31, 2022. For fiscal 2022 it was $3.46M, down 77.5% from the year before. The highest annual figure on record is $19.86M in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $3.46M | -77.5% |
| FY2021 | Dec 31, 2021 | $15.37M | +207.5% |
| FY2020 | Dec 31, 2020 | $5.00M | -74.8% |
| FY2019 | Dec 31, 2019 | $19.86M | +3.0% |
| FY2018 | Dec 31, 2018 | $19.28M | +1.1% |
| FY2017 | Dec 31, 2017 | $19.06M | +3.7% |
| FY2016 | Dec 31, 2016 | $18.38M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $3.46M | -77.5% |
| Q3 FY2022 | Sep 30, 2022 | $3.91M | -65.0% |
| Q2 FY2022 | Jun 30, 2022 | $2.00M | -81.3% |
| Q1 FY2022 | Mar 31, 2022 | $2.00M | -80.3% |
| Q4 FY2021 | Dec 31, 2021 | $15.37M | +207.5% |
| Q3 FY2021 | Sep 30, 2021 | $11.17M | -43.8% |
| Q2 FY2021 | Jun 30, 2021 | $10.67M | -45.5% |
| Q1 FY2021 | Mar 31, 2021 | $10.17M | -47.6% |
| Q4 FY2020 | Dec 31, 2020 | $5.00M | -74.1% |
| Q4 FY2019 | Dec 31, 2019 | $19.86M | +3.8% |
| Q2 FY2019 | Jun 30, 2019 | $19.56M | -0.0% |
| Q1 FY2019 | Mar 31, 2019 | $19.42M | +0.6% |
| Q4 FY2018 | Dec 31, 2018 | $19.28M | +1.1% |
| Q3 FY2018 | Sep 30, 2018 | $19.14M | +9.5% |
| Q2 FY2018 | Jun 30, 2018 | $19.57M | +4.4% |
| Q1 FY2018 | Mar 31, 2018 | $19.31M | +4.7% |
| Q4 FY2017 | Dec 31, 2017 | $19.06M | +3.7% |
| Q3 FY2017 | Sep 30, 2017 | $17.48M | -3.5% |
| Q2 FY2017 | Jun 30, 2017 | $18.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.44M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.38M | – |
| Q3 FY2016 | Sep 30, 2016 | $18.11M | – |
See a number that looks wrong?